DNLI
Denali Therapeutics Inc. Common Stock
$20.13
0.35%
+0.07
Notify me if price changes either direction
Buy DNLI stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.2B
Enterprise value
2.5B
Trailing PE
-6.7744110569809
Forward PE
-8.291003
PEG Ratio
1.2193939902566
Enterprise to EBITDA
-4.816
Enterprise to revenue
703.039
Price to book MRQ
3.8370311
Price to sales TTM
889.71674
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
3.6M
EBITDA
-526057984
Diluted EPS TTM
-2.84
Total Cash (MRQ)
710.5M
Current ratio (MRQ)
8.369
Operating Cash Flow (TTM)
-434040000
DNLI trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
September 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
